Benlysta and Atacand drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Benlysta (belimumab) and Atacand (candesartan cilexetil). Common drug interactions include hyperaesthesia among females and blood glucose increased among males.

The phase IV clinical study analyzes what interactions people have when they take Benlysta and Atacand. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Benlysta?

Benlysta has active ingredients of belimumab. It is often used in systemic lupus erythematosus. eHealthMe is studying from 23,528 Benlysta users. Check the latest studies of Benlysta.

What is Atacand?

Atacand has active ingredients of candesartan cilexetil. It is often used in high blood pressure. eHealthMe is studying from 22,473 Atacand users. Check the latest studies of Atacand.

On Jul, 07, 2026

17 people who take Benlysta and Atacand together, and have interactions are studied.

What are the common drug interactions of Benlysta and Atacand, by gender? *:

female:

Hyperaesthesia
Intestinal stenosis (partial obstruction that causes the centre opening of the intestine to become narrower)
Malaise (a feeling of general discomfort or uneasiness)
Ovarian cyst ruptured (tear in fluid filled sac of the ovary)
Pain of skin
Abdominal pain lower
Bladder disorder
Burning sensation
Pneumonia
Kidney infection

male:

Blood glucose increased
Throat irritation

What are the common drug interactions of Benlysta and Atacand, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Activities of daily living impaired
Nausea (feeling of having an urge to vomit)
Vomiting

40-49:

Cough
Fatigue (feeling of tiredness)
Rash
Abdominal pain
Abdominal pain upper
Arthralgia (joint pain)
Asthenia (weakness)
Chest discomfort
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
Gait disturbance

50-59:

Nausea (feeling of having an urge to vomit)
Bladder pain
Chest discomfort
Chest pain
Dizziness
Dry eye (lack of adequate tears)
Dry mouth
Headache (pain in head)
Hyperaesthesia
Intestinal stenosis (partial obstruction that causes the centre opening of the intestine to become narrower)

60+:

Cough
Diarrhoea
Upper-airway cough syndrome
Viral infection
Fatigue (feeling of tiredness)
Malaise (a feeling of general discomfort or uneasiness)
Migraine (headache)
Myalgia (muscle pain)
Nausea (feeling of having an urge to vomit)
Pyrexia (fever)

What are the existing conditions these people have? *

Pollakiuria (abnormally frequent passage of relatively small quantities or urine): 6 people, 35.29%
Ill-Defined Disorder: 6 people, 35.29%
Osteoporosis (bones weak and more likely to break): 1 person, 5.88%
Joint Pain: 1 person, 5.88%
High Blood Cholesterol: 1 person, 5.88%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 5.88%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 5.88%
Diabetes: 1 person, 5.88%
Depression: 1 person, 5.88%
Dementia (madness): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Benlysta and Atacand?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously